封面
市场调查报告书
商品编码
1527797

整形外科植入市场规模、份额和成长分析:按产品、手术、最终用户和地区 - 行业预测,2024-2031 年

Orthopedic Implants Market Size, Share, Growth Analysis, By Product, By Procedure(Open Surgery, Minimally Invasive Surgery, and Others), By End User, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

到2022年,全球整形外科植入市场价值将达到241.5亿美元,预测期内(2024-2031年)复合年增长率为3.5%,从2023年的250亿美元增长到2031年,预计将达到329.2亿美元。

由于多种因素,整形外科植入市场正在蓬勃发展。骨质疏鬆症和退化性疾病等与骨骼相关的问题的激增正在推动对解决方案的需求。先进植入的出现和医疗保健基础设施的改进进一步支持了成长。材料和设计方面的技术进步促进了更耐用和生物相容性植入的开发,改善了患者的治疗效果。微创手术技术越来越受欢迎,提供了侵入性较小的治疗选择和更快的恢復时间。世界人口老化也导致骨相关疾病发生率增加,需要更多的整形外科干预措施。运动伤害在活跃人群中很常见,也促进了市场的成长。此外,人们对早期疗育和治疗益处的认识不断提高,导致更多患者选择手术解决方案。然而,物理治疗和药物治疗等补充治疗可能会在一定程度上限制植入的需求。此外,整形外科植入和手术的高成本以及某些地区的报销问题可能会对市场成长造成挑战。

目录

介绍

  • 研究目的
  • 定义
  • 市场范围

调查方法

  • 资讯采购
  • 次要/一级资讯来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 市场概况展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 波特的分析

主要市场考察

  • 技术分析
  • 价格分析
  • 价值链分析
  • 专利分析
  • 市场生态系统
  • PESTLE分析
  • 管道分析
  • 监管环境
  • 创新矩阵
  • 重点投资分析
  • 关键成功因素
  • 竞争程度

整形外科植入市场:副产品

  • 市场概况
  • 下肢植入
    • 膝关节植入
    • 髋植入
    • 脚和脚踝植入
  • 脊椎移植
  • 牙科
    • 人工植牙
    • 颅颚颜面植入
  • 上肢植入
    • 手肘植入
    • 手和腕部植入
    • 肩部植入

整形外科植入:依最终用途分类

  • 市场概况
  • 医院
  • 门诊设施

整形外科植入市场规模:依地区划分

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市场占有率(2023年)

主要企业简介

  • JMA Wireless (US)
  • Verana Networks (US)
  • Celona (US)
  • Mangata Networks (US)
  • Airspan Networks (US)
  • EdgeQ (US)
  • Omniflow (US)
  • Aarna Networks (US)
  • Zimmer Biomet Holdings, Inc. (US)
  • Stryker Corporation (US)
  • Johnson & Johnson (DePuy Synthes) (US)
  • Smith & Nephew plc (United Kingdom)
  • Medtronic plc (Ireland)
  • Conmed Corporation (US)
  • Arthrex, Inc. (US)
  • NuVasive, Inc. (US)
  • Globus Medical, Inc. (US)
  • Integra LifeSciences Corporation (US)
  • Aesculap Implant Systems, LLC (Germany)
  • Acumed LLC (US)
  • BioTek Instruments, Inc. (US)
  • MicroPort Scientific Corporation (China)
  • Colfax Corporation (DentalEZ Group) (US)
  • Ossur hf (Iceland)
  • Waldemar Link GmbH & Co. KG (Germany)
  • LimaCorporate SpA (Italy)
  • ConforMIS, Inc. (US)
  • Invibio Biomaterial Solutions (UK)
  • Alphatec Holdings, Inc. (US)
  • Corin Group (UK)
  • FH Orthopedic (France)
  • Medacta (Switzerland)
  • Pega Medical (Canada)
  • Orthofix Medical, Inc. (US)
简介目录
Product Code: SQMIG35A2224

Global Orthopedic Implant Market was valued at USD 24.15 billion in 2022 and is expected to rise from USD 25 billion in 2023 to reach a value of USD 32.92 billion by 2031, at a CAGR of 3.5% during the forecast period (2024-2031).

The orthopedic implants market is thriving due to several factors. A surge in bone-related issues like osteoporosis and degenerative disorders is driving demand for solutions. The availability of advanced implants and improving healthcare infrastructure are further boosting growth. Technological advancements in materials and design have led to the development of more durable and biocompatible implants, enhancing patient outcomes. Minimally invasive surgical techniques are gaining popularity, offering less invasive treatment options with faster recovery times. An aging global population is also contributing to the increased incidence of bone-related conditions, necessitating more orthopedic interventions. Sports injuries, a common occurrence among active populations, also contribute to the market's expansion. Furthermore, rising awareness about the benefits of early intervention and treatment is encouraging more patients to opt for surgical solutions. However, complementary treatments like physical therapy and medications can potentially limit the demand for implants to some extent. Additionally, the high cost of orthopedic implants and surgeries, coupled with reimbursement issues in some regions, may pose challenges to market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Orthopedic Implants Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Orthopedic Implants Market Segmental Analysis

The global orthopedic implants market is segmented based on product, procedure, end user, and region. By product, the market is segmented into Lower Extremity Implants (Knee Implants, Hip Implants, Foot & Ankle Implants), Spinal Implants, Dental (Dental Implants, Craniomaxillofacial Implants), and Upper Extremity Implants (Elbow Implants, Hand & Wrist Implants, Shoulder Implants). By end user, the market is segmented into Hospitals and Outpatient Facilities. By region, the global orthopedic implants market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Orthopedic Implants Market

The surge in orthopedic implant demand is primarily driven by the escalating prevalence of musculoskeletal disorders. Conditions such as osteoarthritis, rheumatoid arthritis, osteoporosis, and sports-related injuries are on the rise, particularly among the aging population. This demographic shift, coupled with increased physical activity levels, has created a significant market for orthopedic solutions.

Restraints in the Global Orthopedic Implants Market

Inadequate reimbursement for orthopedic implants presents a major hurdle to market expansion. Patients often bear significant out-of-pocket costs for both the implant and surgery, deterring many from essential treatments. This financial strain disproportionately affects lower-income populations, limiting access to critical care. As a result, healthcare providers and implant manufacturers grapple with balancing cost-efficiency and the imperative for high-quality, innovative solutions. This intricate interplay of factors creates a complex market landscape.

Market Trends of the Global Orthopedic Implants Market

3D printing technology is being increasingly used in the development of orthopedic implants, as it allows for the production of highly customized and complex implants that can better match the patient's anatomy. The use of 3D printing technology also enables the creation of bioresorbable implants that can gradually degrade in the body over time, eliminating the need for a second surgery to remove the implant.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • Patent Analysis
  • Ecosystem of the Market
  • PESTLE Analysis
  • Pipeline Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Global Orthopedic Implants Market by Product

  • Market Overview
  • Lower Extremity Implants
    • Knee Implants
    • Hip Implants
    • Foot & Ankle Implants
  • Spinal Implants
  • Dental
    • Dental Implants
    • Craniomaxillofacial Implants
  • Upper Extremity Implants
    • Elbow Implants
    • Hand & Wrist Implants
    • Shoulder Implants

Global Orthopedic Implants Market by End-use

  • Market Overview
  • Hospitals
  • Outpatient Facilities

Global Orthopedic Implants Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

    • JMA Wireless (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Verana Networks (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Celona (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mangata Networks (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Airspan Networks (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EdgeQ (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Omniflow (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aarna Networks (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet Holdings, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (DePuy Synthes) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Conmed Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arthrex, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NuVasive, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Globus Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aesculap Implant Systems, LLC (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acumed LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioTek Instruments, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Colfax Corporation (DentalEZ Group) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ossur hf (Iceland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Waldemar Link GmbH & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LimaCorporate S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ConforMIS, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Invibio Biomaterial Solutions (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alphatec Holdings, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corin Group (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FH Orthopedic (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medacta (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pega Medical (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orthofix Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments